Liposome drug in-vivo biological analysis method

A technology of bioanalysis and liposome, which is applied in the field of medicine, can solve the problems of not effectively reflecting the bioavailability of drugs, and achieve the effect of precise release degree

Active Publication Date: 2022-04-12
南京美新诺医药科技有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In view of the complex interaction between drug release in liposomes and tissue and/or cell uptake of drugs and/or liposomes, only simple

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liposome drug in-vivo biological analysis method
  • Liposome drug in-vivo biological analysis method
  • Liposome drug in-vivo biological analysis method

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0036] Example 1: Total multi-soft extraction process (low concentration quantitative range)

[0037] 1. All samples to be tested are completely melted, mix well for 10 to 30 seconds.

[0038] 2. Make 50 μl of the sample to be tested to 1.5 ml of the centrifuge tube, add 50 μl of concentration of 100 ng / ml of IS solution, mix uniform, to obtain a sample to be tested in the internal standard; 50 μl of blank sample (ie 50 μl of blank plasma) to 1.5 In the ml centrifuge tube, 50 μl of the concentration of 100 ng / ml of IS solution was added, mixed uniform, gave a blank internal standard control; 50 μl of whitesample (ie 50 μl of blank plasma) to 1.5 ml of centrifuge tube, add 50 μl of methanol: water (1) : 1), mix well, get a blank control.

[0039]3. 800 μl of chloroform is added to the inner standard, and 800 μl of chloroform is added to the blank internal standard, and the vortex was centrifuged for 3 minutes at 10,000 × g, 4 ° C.

[0040] 4. Remove the underlying organic phase...

Example Embodiment

[0043] Example 2: Total multi-soft extract (high concentration quantitative range)

[0044] 1. All samples to be tested are completely melted, mix well for 10 to 30 seconds.

[0045] 2. Remove 50 μL to be tested to 1.5 ml of the centrifuge tube, add 50 μl of the concentration of 500 ng / ml of IS solution, mix well, to obtain a sample to be tested in the internal standard; 50 μl blank sample (ie 50 μl of blank plasma) to 1.5 In the ml centrifuge tube, 50 μl of concentration of 500 ng / ml is added, mix uniform, gave a blank internal standard control; 50 μl of blank sample (ie 50 μl of blank plasma) to 1.5 ml of centrifugal tube, add 50 μl of methanol: water (1) : 1), mix well, get a blank control.

[0046] 3. 800 μl of chloroform is added to the inner standard, and 800 μl of chloroform is added to the blank internal standard, and the vortex was centrifuged for 3 minutes at 10,000 × g, 4 ° C.

[0047] 4. Remove the underlying organic phase 200 μL to 96-well plates, dry samples at 3...

Example Embodiment

[0050] Example 3: The extraction process of the multirodynamic packed star wrapped in liposomes (low concentration quantitative range)

[0051] 1. All samples to be tested are completely melted, mix well for 10 to 30 seconds.

[0052] 2. Add 100 μl of water to a 50 μl of the sample, mix well, and mixed samples.

[0053] 3. 1 ml of methanol and water activated SPE solid phase extraction plate (Strata C18-E) were added sequentially.

[0054] 4. Sequentially transfer all of the above mixed samples and 150 μl of water to an activated solid phase extraction plate, and the effluent is collected.

[0055] 5. Add 50 μl of the concentration of 100 ng / ml of IS solution to the effluent, mix well, to obtain a sample to be tested in the inner standard. 50 μl of blank sample (i.e., 50 μl of blank plasma) alternatively operated the 50 μl of the sample to be tested in step 5 to step 5, resulting in a blank internal standard control; 50 μl blank sample (ie, 50 μl of blank plasma) is replaced by ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides an in-vivo biological analysis method for a liposome drug. The total content of the liposome drug is detected by adopting a liquid-liquid extraction method and LC-MS/MS (Liquid Chromatography-Mass Spectrometry/Mass Spectrometry); a solid-phase extraction method, a liquid-liquid extraction method and LC-MS/MS are adopted to detect the content of the liposome wrapped medicine; and the content of the free liposome drug is obtained by subtracting the content of the liposome-coated drug from the total liposome drug content. According to the invention, after the liposome drug enters the body, the in-vivo free drug and the liposome wrapping part are effectively measured, and reference is provided for the in-vivo pharmacokinetic behavior of the liposome and the in-vivo release degree of the preparation. Compared with a traditional method for measuring the sum of the in-vivo lipidosome and the free medicine through protein precipitation, the method has the advantage that the release degree of the in-vivo lipidosome can be reflected more accurately.

Description

technical field [0001] The invention belongs to the field of medicine, in particular to a bioanalysis method for liposome medicine in vivo. Background technique [0002] Liposomes are vesicles composed of a single bilayer (unilamellar) and / or a series of concentric bilayers (multilamellar) separated by aqueous compartments formed by amphiphilic phospholipids, the closed center being aqueous Compartment. [0003] In liposomal drugs, the drug is usually encapsulated inside the liposome, generally water-soluble drugs are encapsulated in the aqueous compartment (1 or more), lipophilic drugs are encapsulated in the lipid bilayer Medium (1 or more). [0004] Liposomal drugs differ from emulsions, microemulsions, and drug-lipid mixtures in that the drug release behavior from liposomes, as well as other properties such as liposomal clearance and circulation half-life, may vary depending on polyethylene glycol and / or cholesterol or other The addition of possible liposome additives...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N30/06G01N30/02G01N30/72G01N1/34G01N1/40
CPCY02A50/30
Inventor 高峥贞张玲玲卢金莲
Owner 南京美新诺医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products